Loading organizations...

ZETA SURGICAL: Develops AI-powered surgical navigation systems using computer vision for precise, real-time, marker-less guidance in complex procedures.
ZETA SURGICAL has raised $9.0M across 1 funding round.
Key people at ZETA SURGICAL.
ZETA SURGICAL was founded in 2018 by Raahil Sha (Founder/CTO) and Jose Maria Amich (Founder/CEO).
ZETA SURGICAL has raised $9.0M in total across 1 funding round.
Boston, Massachusetts-based Zeta Surgical is a medical technology company that develops artificial intelligence-powered, computer vision-guided navigation systems for minimally invasive procedures. Operating with a team of 12 employees, the venture-funded startup builds hardware and software platforms, including the FDA-cleared Zeta Cranial and Zeta TMS navigation systems. These platforms provide real-time instrument tracking for neurosurgeons and clinicians in hospitals and outpatient centers without requiring rigid skull pins or bulky operating room equipment. Generating under $5 million in annual revenue, the company has raised a $5.2 million seed round and is backed by lead investors including Y Combinator, Innospark Ventures, and Plug and Play Ventures. The firm positions its markerless tracking technology alongside established industry competitors like Medtronic and Brainlab following initial clinical integration at Singapore General Hospital. Zeta Surgical was founded in 2018 by Jose Maria Amich and Raahil Sha.
ZETA SURGICAL was founded in 2018 by Raahil Sha (Founder/CTO) and Jose Maria Amich (Founder/CEO).
ZETA SURGICAL has raised $9.0M in total across 1 funding round.
ZETA SURGICAL's investors include Innospark Ventures, First Star Ventures, LAUNCH, Sunset Ventures, TSVC Capital, Trevor Fetter.
Key people at ZETA SURGICAL.
Zeta Surgical is a next-generation digital surgery company that develops advanced surgical navigation and robotics tools aimed at making minimally invasive surgeries easier, faster, and more accessible. Their flagship product, the ZETA platform, leverages artificial intelligence (AI), computer vision, and mixed reality to provide real-time, highly accurate image guidance during neurosurgical and interventional procedures. This technology enables surgeons to perform complex operations with improved precision and safety, often without the need for invasive skull fixation or general anesthesia. Zeta Surgical primarily serves neurosurgeons and hospitals, addressing critical challenges in emergency care, brain cancer treatment, and neuromotor disorder interventions. The company has demonstrated strong growth momentum, marked by successful clinical trials, FDA clearances, and strategic partnerships with leading hospitals and design firms[1][2][4][6][8].
Founded in 2018 by Harvard graduates Jose Amich (CEO) and Raahil Sha (CTO), alongside Harvard Medical School neurosurgeon William Gormley, Zeta Surgical emerged from a shared vision to revolutionize neurosurgery through technology. The founders combined expertise in computer science, medicine, and management (Amich and Gormley are MIT Sloan MBA alumni) to create a system that overcomes the limitations of traditional surgical navigation. Early traction included securing seed funding of $5.2 million, completing multi-center clinical trials in Singapore, and receiving FDA 510(k) clearance for cranial surgical procedures. These milestones validated the technology’s potential and set the stage for broader adoption[2][4][6].
Zeta Surgical rides the convergence of AI, robotics, and mixed reality in healthcare, a trend accelerating the shift toward precision, minimally invasive surgery. The timing is critical as healthcare systems demand safer, faster, and more cost-effective surgical solutions that can be deployed beyond traditional operating rooms, including emergency and outpatient settings. Market forces such as rising neurological disease prevalence, increasing demand for image-guided interventions, and advances in AI-driven medical devices favor Zeta’s growth. By democratizing access to high-precision neurosurgery, Zeta Surgical influences the broader ecosystem by enabling new treatment paradigms and reducing healthcare costs, potentially transforming surgical standards globally[1][3][4][6].
Looking ahead, Zeta Surgical is poised to expand its product indications and geographic reach, leveraging ongoing clinical trials and regulatory clearances. Trends shaping its journey include the integration of focused ultrasound for intracranial drug delivery, further AI enhancements, and broader adoption of mixed reality in surgery. As the company scales, its influence may extend beyond neurosurgery into other interventional fields, driving a new era of digital, patient-centric surgical care. Zeta’s commitment to accessibility and innovation positions it as a transformative player in the surgical robotics landscape, fulfilling its mission to improve outcomes and efficiency in critical surgical procedures[4][6][8].
ZETA SURGICAL has raised $9.0M across 1 funding round. Most recently, it raised $9.0M Seed in March 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2022 | $9.0M Seed | Innospark Ventures | First Star Ventures, LAUNCH, Sunset Ventures, TSVC Capital, Trevor Fetter |